Holen Sie sich die Stockscreener-App
5.33
0.19%
-0.010
Handel nachbörslich:
5.34
0.010
+0.19%
Schlusskurs vom Vortag:
$5.34
Offen:
$5.4
24-Stunden-Volumen:
6,852
Relative Volume:
0.21
Marktkapitalisierung:
$34.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-71.07M
KGV:
-10.88
EPS:
-0.49
Netto-Cashflow:
$-63.98M
1W Leistung:
-7.14%
1M Leistung:
-31.05%
6M Leistung:
-35.78%
1J Leistung:
-34.54%
1-Tages-Spanne:
$5.2101
$5.56
1-Wochen-Bereich:
$5.2101
$5.9525
52-Wochen-Spanne:
$4.2701
$19.00
Vicarious Surgical Inc Stock (RBOT) Company Profile
Firmenname
Vicarious Surgical Inc
Sektor
Branche
Telefon
(617) 868-1700
Adresse
78 FOURTH AVENUE, WALTHAM
Vergleichen Sie RBOT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
5.33 | 34.04M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Eingeleitet | Credit Suisse | Outperform |
| 2021-12-07 | Eingeleitet | Cowen | Outperform |
| 2021-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-10-18 | Eingeleitet | BTIG Research | Buy |
| 2021-10-07 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Vicarious Surgical Inc Aktie (RBOT) Neueste Nachrichten
(RBOT) Investment Analysis - news.stocktradersdaily.com
Vicarious Surgical receives continued listing standard notice - Medical Buyer
Vicarious Surgical receives continued listing standard notice from NYSE - MSN
Vicarious Surgical Faces NYSE Non-Compliance Notice - TipRanks
Vicarious Surgical Receives NYSE Noncompliance Notice - MarketScreener
Vicarious Surgical Receives Continued Listing Standard Notice From The NYSE - marketscreener.com
NYSE Warning: Vicarious Surgical Must Boost Market Cap or Face Potential Delisting - Stock Titan
Vicarious Surgical enters consulting agreement with former CFO - MSN
(RBOT) Long Term Investment Analysis - news.stocktradersdaily.com
RBOTVicarious Surgical Announces Reverse Stock Split - ADVFN
Vicarious Surgical President Randy Clark to Become Board Member - MPO-mag
Learn to Evaluate (RBOT) using the Charts - news.stocktradersdaily.com
Vicarious Surgical President Randy Clark to Transition to Board Member - citybiz
Vicarious Surgical president shifts to board role By Investing.com - Investing.com South Africa
Vicarious surgical CEO sells $1,275 in stock By Investing.com - Investing.com Australia
Vicarious Surgical Announces President Transition to Board Member Role - Ortho Spine News
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock - Investing.com
Vicarious surgical CEO sells $1,275 in stock - Investing.com
Vicarious Surgical president shifts to board role - Investing.com India
Vicarious Surgical announces president transition to board member role -March 24, 2025 at 04:31 pm EDT - MarketScreener
Strategic Leadership Shift: Vicarious Surgical President Elevates to Board Role After Key Achievements - Stock Titan
Vicarious Faces Another Delay for FDA Submission - MD+DI
Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Growth in Short Interest - Defense World
Monogram robot wins FDA OK; Vicarious hit by supplier woes - MedTech Dive
Vicarious Surgical’s Earnings Call: Achievements and Challenges - TipRanks
Piper Sandler cuts Vicarious Surgical stock target to $8.50 By Investing.com - Investing.com Australia
Piper Sandler cuts Vicarious Surgical stock target to $8.50 - Investing.com India
BTIG maintains Neutral on Vicarious Surgical stock post-results By Investing.com - Investing.com Australia
BTIG maintains Neutral on Vicarious Surgical stock post-results - Investing.com
Vicarious Surgical Inc. (NYSE:RBOT) Q4 2024 Earnings Call Transcript - MSN
Vicarious Surgical reports net loss of USD 14.4M in Q4 2024 - Medical Buyer
Vicarious Surgical Inc (RBOT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Cost ... By GuruFocus - Investing.com Canada
Vicarious Surgical Reports 2024 Financial Results and Progress - TipRanks
Earnings call transcript: Vicarious Surgical Q4 2024 financials and outlook - Investing.com
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results - OrthoSpineNews
Earnings call transcript: Vicarious Surgical Q4 2024 financials and outlook By Investing.com - Investing.com Australia
Vicarious Surgical Inc. SEC 10-K Report - TradingView
Vicarious Surgical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vicarious Surgical Names Sarah Romano as Finance Chief - MPO-mag
Earnings Scheduled For March 17, 2025Altus Power (NYSE:AMPS), Bakkt Hldgs (NYSE:BKKT) - Benzinga
Vicarious Surgical names Sarah Romano as CFO - Medical Buyer
(RBOT) Trading Report - news.stocktradersdaily.com
Vicarious Surgical Inc expected to post a loss of $2.69 a shareEarnings Preview - TradingView
Vicarious Surgical appoints Sarah Romano as CFO - MedTech Dive
Vicarious Surgical Appoints Sarah Romano as Chief Financial Officer - citybiz
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer - OrthoSpineNews
Vicarious Surgical appoints Sarah Romano as CFO -March 13, 2025 at 10:22 am EDT - Marketscreener.com
Vicarious Surgical names Sarah Romano as new CFO - Investing.com India
Vicarious Surgical Appoints New Chief Financial Officer - TipRanks
Vicarious Surgical names Sarah Romano as new CFO By Investing.com - Investing.com South Africa
Finanzdaten der Vicarious Surgical Inc-Aktie (RBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):